LISBON (MedPage Today) -- Renal function got worse when aliskiren (Tekturna) was given on top of standard therapy with ACE inhibitors or angiotensin receptor blockers to patients with heart failure and renal impairment, a small trial showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment